Bristol-Myers hits snag in plan to catch Merck in lung cancer - BioPharma Dive

Bristol-Myers hits snag in plan to catch Merck in lung cancer  BioPharma Dive

Bristol-Myers Squibb's chances of challenging Merck & Co. in the market for lung cancer drugs shrank on Wednesday, when the pharma announced mixed ...



Comments

Popular posts from this blog

Oncology: The disease, dynamics & challenges of market research

A Review of the Etiology and Epidemiology of Bladder Cancer: All ...

Lung Cancer Among People Who Never Smoked